Heparin-Induced Thrombocytopenia: Acknowledging Its Presence in Low-Molecular Weight Heparin Therapy
β Scribed by Heng Joo Ng; Lai Heng Lee
- Publisher
- Carden Jennings Publishing
- Year
- 2003
- Tongue
- English
- Weight
- 71 KB
- Volume
- 77
- Category
- Article
- ISSN
- 0925-5710
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The incidence of antibodies to heparin-PF4 complexes (H-PF4) has been evaluated in patients who were under heparin therapy for more than 7 days: 109 patients treated with unfractionated heparin (UH) and 100 patients with low-molecular-weight heparin (LMWH). The presence of antibodies was identified
## Abstract No data are available regarding the management of cancer patients requiring interruption of longβterm vitaminβK antagonist (VKA) therapy. For this purpose, we tested the efficacy and safety of fixed doses of lowβmolecular weight heparin (LMWH) in substitution of VKA because of invasive